Bone produced from skin and ...( erse Jell-O remaining liquid when coo...)

Bone produced from skin and gum tissue

erse Jell-O," remaining liquid when cool and firming up when warm, says Rutherford. Injected as liquid into a lesion of any size or shape, the material gels as it warms to body temperature, holding the engineered cells in the appropriate place.

In another set of experiments reported in the paper, the researchers implanted engineered human gingival cells into a strain of mouse that has no immune system and therefore does not reject foreign tissue. To their surprise, the new bone that formed in the mice was composed of both mouse and human tissue. "This suggests that the gingival cells were not just delivering BMP-7, but also responding to the protein and making bone themselves," says Rutherford.

Using a patient's own cells from easily accessed tissues that heal quickly is a major step toward an alternative to conventional bone grafts, Rutherford says. "If the implanted cells form bone directly, in addition to secreting BMP-7, these autografts would be useful in regenerating bone in the many cases where few cells capable of forming new bone remain in the injured bone. Such lesions are difficult to treat by conventional treatment."

'"/>

Contact: Nancy Ross-Flanigan
rossflan@umich.edu
734-647-1853
University of Michigan
18-May-2000

Page: 1 2
Related biology news :

1. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
2. Biologists discover nerve activity, not just genetics controls kinds of neurotransmitters produced
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Transgenic animals produced using cultured sperm
5. Genetically modified crops in India produced greater yields, reduced pesticide use, new study finds
6. Ozone produced by antibodies during bacterial killing and in inflammation
7. Hormones modify the type of proteins produced
8. Iron-binding compounds produced by marine bacteria have important implications for marine microbial ecology
9. Neurons produced during adulthood react to stimuli
10. Researchers at Virginia Tech and CropTech Corp. receive patent for lysosomal enzymes produced in plants
11. Human Bone Disorder Reproduced In Mice

Post Your Comments:

(Date:11/23/2009)...RE, Calif. - By producing some of the highest reso...faces, scientists have a deeper understanding how ...research may lead to a new treatment for kidney st...ppears in the Nov. 23 online edition of the journa... , explores how peptides interact with mineral sur...

(Date:11/23/2009)...MINGHAM, Ala. A new study by University of Alabam...mass index (BMI) and co-existing medical condition...ival observed among African-Americans compared to ...s published online Nov. 23 in Cancer , a journal ...dicates that although BMI and co-morbidity are ind...

(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...

[0] Scientists watch as peptides control crystal growth with 'switches, throttles and brakes'[0] Racial disparity in colon cancer survival not easily explained, UAB researchers say [0] Computational microscope peers into the working ribosome

(Date:11/24/2009)...ntly approved the Promega PowerPlex 16 HS System f...ing DNA records for the National DNA Index System....) -- The FBI recently approved the Promega PowerP...ticipating in, or generating DNA records for, the ...ontains more than seven million profiles and has a...

(Date:11/24/2009)...irstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegl...cedthatithassubmittedaMAAtotheEuropeanMedicinesAge...menttherapyindevelopment,forthetreatmentofType1Gau...velaglucerasealfathathasbeensubmitted,withprevious...edonaglobalsupplyshortageofthecurrentlyapprovedand...

(Date:11/24/2009)...ire/--HealthRoboticstodayannounced,thatithasformed...tors.ThisrecentlyformedToronto-basedcompanywillope...arket,install,andsupport,HealthRobotics,i.v.Roomof...ductofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(T...nceonan"asneeded,basis"toitsstrategicpartnershipsw...

(Date:11/24/2009)...tCall/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CT...yHealthCareConference.TheconferencewillbeheldDecem...presentonTuesday,December1at11:00a.m.EasternTimein...tionwillbeavailableat www.celltherapeutics.com ,an...erJaffrayHealthCareConference,NewYorkPalaceHotel,H...

Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3 Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2

[0] NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease [0] Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada [0] Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference

Other News:

...ole in the molecular machinery for making HIV-1 (t...scientists from the National Institute of Standard... working at the Center for Advanced Research in Bi...the mechanism, described in the Jan. 20 online edi...

...the Stanford Synchrotron Radiation Laboratory (SSR...acility, SPEAR3, guarantees a world-class program ...retary of Energy Spencer Abraham. "This is the fir...Institutes of Health have joined in funding an acc...

..., Low Cholesterol Diets......It is well known that...reased risk for coronary heart disease a major ca...erapeutic approach is to follow a diet low in satu...fect of this therapeutic diet on cholesterol respo...

...launched a new initiative to speed research on ner... that attacks the brain and spinal cord. The Socie...mpete for grants of up to $5.5 million each to pav...ction strategies in people with MS. ......"The pac...

Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 2 Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 3 Highlights of Tufts University nutrition research: January 2004 2 Highlights of Tufts University nutrition research: January 2004 3 Highlights of Tufts University nutrition research: January 2004 4

'Kissing' RNA and HIV-1: Unraveling the details Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory Highlights of Tufts University nutrition research: January 2004 Largest brain repair initiative in MS will speed strategies to restore nerve function

..., 2005 -- Results from a Phase 2 rheumatoid arthri...f golimumab (CNTO 148), a fully-human anti-TNF-alp...dpoint of the study. In this dose-ranging trial, ...o severely active RA treated with golimumab and me...

...s with the University of Florida and the Californi...ain of genetically modified mice that allow scient...erapies for Alzheimer's disease.......The developm...cess medical journal PloS Medicine, has helped sci...

It sounds like science fiction: simply swallowing a pill, or eating a specific food supplement, could permanently change your behaviour for the better, or reverse diseases such as schizophrenia, Hunti

...ardiology researchers at Cedars-Sinai Medical Cent...s virus engineered to carry a beneficial, mutant g...y of the gene's protein product that protects agai...the amount of plaque was significantly reduced, as...

Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 2 Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 3 Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 4 Scientists engineer mice to mimic Alzheimer's therapy 2 The food you eat could change your genes 2 The food you eat could change your genes 3 Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 2 Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 3

Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial Scientists engineer mice to mimic Alzheimer's therapy The food you eat could change your genes Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque